Cochrane Abstracts
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tacrolimus Versus Cyclosporin as Primary Immunosuppression for Lung Transplant Recipients." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients_New. Accessed 23 September 2023.
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients_New. Accessed September 23, 2023.
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients_New
Tacrolimus Versus Cyclosporin as Primary Immunosuppression for Lung Transplant Recipients [Internet]. In: Cochrane Abstracts. [cited 2023 September 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
ID - 438880
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438880/all/Tacrolimus_versus_cyclosporin_as_primary_immunosuppression_for_lung_transplant_recipients_New
DB - Evidence Central
DP - Unbound Medicine
ER -
